# 77 Capital

> 77 Capital is a VC fund in Sendai backing Medical and Robotics. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Sendai, Japan
- Total investments: 10
- Last investment: Aug 2025
- Lead investor: 10%
- Last updated: Aug 2026

77 Capital is a VC fund in Sendai focused on Medical and Robotics. 77 Capital is the venture arm of 77 Bank.

## Contacts

5 contacts available for 77 Capital. Shizune tracks 1 team members at 77 Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/77-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 20% |
| Robotics | 2 | 20% |
| Software | 2 | 20% |
| Health Care | 2 | 20% |
| Manufacturing | 2 | 20% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 30% |
| Series B | 3 | 30% |
| Seed | 1 | 10% |
| Pre-Seed | 1 | 10% |
| Series C | 1 | 10% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 9 | 90% |
| United States | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Konno Akira | President and CEO | 2 | https://shizune.co/investors/profile/konno-akira |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| 3DC | 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices. | $16.7M | Series A | Aug 04, 2025 |  |
| Airato | Airato specializes in the development of radiation therapy using artificial intelligence technology. | $3.2M | Seed | Jun 24, 2025 |  |
| Solaris | Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan. | $195K | Venture - Series Unknown | Jul 29, 2024 |  |
| Hirosaki Lifescience Innovation | Hirosaki Lifescience Innovation is engaged in the development, manufacture, and sale of regenerative medicine products. | $15.2M | Series C | Jul 22, 2024 |  |
| Girasol Energy | Girasol Energy is an IoT Platform provides innovative PLC technologies that enable wiser PV Plants. |  | Series B | Mar 22, 2024 |  |
| SEQSENSE | SEQSENSE develops autonomous mobile robots and related products. | $12.3M | Series B | Aug 18, 2023 |  |
| yufin | yufin is a merchant platform that enables under-served SMEs in emerging markets to access the digital economy. | $1M | Pre-Seed | Jun 27, 2022 |  |
| Aiforce Solutions | Aiforce Solutions is an able to use AI to solve problems in the AI market.The company provides three main services, from the introduction to the improvement of AI. In the first “AI Development Due Diligence”, AI Implementation Consulting, which leads to customer business reform, and support prototype development at 1/3 of the cost ofcompetitors. In addition, we support the selection of AI vendors to conduct PoC and the technical evaluation of potential investment candidates as a member of our customers | $2.5M | Series A | Sep 14, 2020 |  |
| Renascience | Renascience is a pharmaceuticals company. | $7.1M | Series B | Mar 11, 2019 |  |
| Ball Wave | Ballwave uses the ball SAW sensor based on a new principle as the core of the differentiating factor, and becomes the human eye and the nervous system, and invites it to the horizon of technology. | $32.6M | Series A | Sep 20, 2016 |  |

10 of 10 investments shown.

## Co-investors
- [GxPartners](https://shizune.co/investors/profile/gxpartners) — VC Fund, 3 deals together
- [Central Japan Seed Fund](https://shizune.co/investors/profile/central-japan-seed-fund) — VC Fund, 2 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 2 deals together
- [Sumitomo](https://shizune.co/investors/profile/sumitomo-corporation) — VC Fund, 2 deals together
- [Tohoku University Venture Partners](https://shizune.co/investors/profile/tohoku-university-venture-partners) — VC Fund, 2 deals together
- [UTokyo Innovation Platform](https://shizune.co/investors/profile/utokyo-innovation-platform) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does 77 Capital invest in?

77 Capital invests primarily in Medical, Robotics and Software startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact 77 Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at 77 Capital?

The team at 77 Capital includes Konno Akira (President and CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co